Key facts
- Inovocan’s last known valuation is $440K (Aug 2020).
- It has raised $3.0M; the latest was Later Stage VC ($1.2M) in Feb 2025.
- Notable investors include Maven Capital Partners UK, North of Tyne Growth Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Inovocan
- ·The full record, as it builds
Funding rounds
No funding rounds for Inovocan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Inovocan
Manufacturer of ambient-stable dairy and plant-based canned beverages designed for functional and complex liquid applications. The company's platform integrates specialized thermal retort processing, patented vacuum-assisted cold-brew coffee extraction, and structured technical validation protocols to overcome the stability challenges of milk-based formulations, enabling ambitious beverage brands to transition technically difficult ready-to-drink concepts from small-batch development into commercially viable, shelf-stable products that maintain consistent flavor and nutritional integrity.
- Sector
- Business Products and Services (B2B)
- HQ
- Newcastle upon Tyne, United Kingdom
- Founded
- 2017
- Employees
- 28
- Website
- inovocan.com/
- Ownership
- Privately Held (backing)
Inovocan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inovocan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inovocan in its N-PORT filings yet. We sweep new filings monthly.